Overview

Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease

Status:
Completed
Trial end date:
2017-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if droxidopa reduces fall risk by improving gait speed, kyphosis, and functional reach in individuals with Parkinson's disease.
Phase:
N/A
Details
Lead Sponsor:
Colorado Springs Neurological Associates
Collaborator:
H. Lundbeck A/S
Treatments:
Droxidopa